FDA Booster priority.jpeg

ACEP Urges FDA to Prioritize Emergency Physicians for COVID-19 Booster

Washington, D.C.—From Mark Rosenberg, DO, MBA, FACEP, president of the American College of Emergency Physicians (ACEP):

“While we continue to learn new details about this virus and its vaccines, we know that the increased exposure to the Delta variant adds a level of risk to the daily lives of thousands of frontline health professionals, many of whom received the vaccine in the beginning of the year. As emergency beds continue to fill up in hospitals across the country, we cannot afford to lose physicians on the frontlines.

"Emergency physicians and other health care workers are exposed to patients with COVID-19 every day. We should take every precaution to keep them healthy and able to continue their life-saving work. 

As COVID-19 booster shots begin to get distributed to targeted populations, ACEP urges the U.S. Food and Drug Administration (FDA) to consider emergency physicians and other frontline workers as top priority.”

The American College of Emergency Physicians (ACEP) is the national medical society representing emergency medicine. Through continuing education, research, public education, and advocacy, ACEP advances emergency care on behalf of its 40,000 emergency physician members, and the more than 150 million people they treat on an annual basis. For more information, visit www.acep.org and www.emergencyphysicians.org

Contact: Steve Arnoff | sarnoff@acep.org | Twitter @EmergencyDocs

Advocacy COVID-19 FDA News Vaccines